Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 194 articles:
HTML format



Single Articles


    September 2022
  1. SAPP N, Burge N, Cox K, Prakash P, et al
    HIV-1 Preintegration Complex Preferentially Integrates the Viral DNA into Nucleosomes Containing Trimethylated Histone 3-Lysine 36 Modification and Flanking Linker DNA.
    J Virol. 2022 Sep 12:e0101122. doi: 10.1128/jvi.01011.
    PubMed     Abstract available


  2. ZHANG X, Li J, Zhang M, Bai B, et al
    A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
    J Virol. 2022 Sep 7:e0098622. doi: 10.1128/jvi.00986.
    PubMed     Abstract available


    August 2022
  3. FILES JK, Sterrett S, Henostroza S, Fucile C, et al
    HLA-II-Associated HIV-1 Adaptation Decreases CD4(+) T-Cell Responses in HIV-1 Vaccine Recipients.
    J Virol. 2022 Aug 24:e0119122. doi: 10.1128/jvi.01191.
    PubMed     Abstract available


  4. HE X, Aid M, Ventura JD, Borducchi E, et al
    Rapid Loss of CD4 T Cells by Pyroptosis during Acute SIV Infection in Rhesus Macaques.
    J Virol. 2022 Aug 24:e0080822. doi: 10.1128/jvi.00808.
    PubMed     Abstract available


  5. ANANG S, Richard J, Bourassa C, Goyette G, et al
    Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
    J Virol. 2022 Aug 18:e0063622. doi: 10.1128/jvi.00636.
    PubMed     Abstract available


  6. WOODBURN BM, Kanchi K, Zhou S, Colaianni N, et al
    Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation.
    J Virol. 2022 Aug 17:e0095722. doi: 10.1128/jvi.00957.
    PubMed     Abstract available


  7. DUAN S, Yu X, Wang C, Meng L, et al
    Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
    J Virol. 2022 Aug 11:e0055522. doi: 10.1128/jvi.00555.
    PubMed     Abstract available


  8. JONES ST, Guo K, Cooper EH, Dillon SM, et al
    Altered Immunoglobulin Repertoire and Decreased IgA Somatic Hypermutation in the Gut during Chronic HIV-1 Infection.
    J Virol. 2022 Aug 8:e0097622. doi: 10.1128/jvi.00976.
    PubMed     Abstract available


  9. WANG XQ, Zerbato JM, Avihingsanon A, Fisher K, et al
    Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
    J Virol. 2022 Aug 2:e0058822. doi: 10.1128/jvi.00588.
    PubMed     Abstract available


  10. BUCKMASTER MV, Goff SP
    Riplet Binds the Zinc Finger Antiviral Protein (ZAP) and Augments ZAP-Mediated Restriction of HIV-1.
    J Virol. 2022 Aug 1:e0052622. doi: 10.1128/jvi.00526.
    PubMed     Abstract available


    July 2022
  11. RUDICELL RS, Piel AK, Stewart F, Moore DL, et al
    Correction for Rudicell et al., "High Prevalence of Simian Immunodeficiency Virus Infection in a Community of Savanna Chimpanzees".
    J Virol. 2022 Jul 26:e0045122. doi: 10.1128/jvi.00451.
    PubMed    


  12. WIETGREFE SW, Duan L, Anderson J, Marques G, et al
    Detecting Sources of Immune Activation and Viral Rebound in HIV Infection.
    J Virol. 2022 Jul 20:e0088522. doi: 10.1128/jvi.00885.
    PubMed     Abstract available


  13. ALBALAWI YA, Narasipura SD, Olivares LJ, Al-Harthi L, et al
    CD4(dim) CD8(bright) T Cells Home to the Brain and Mediate HIV Neuroinvasion.
    J Virol. 2022 Jul 19:e0080422. doi: 10.1128/jvi.00804.
    PubMed     Abstract available


  14. MACEDO AB, Levinger C, Nguyen BN, Richard J, et al
    The HIV Latency Reversal Agent HODHBt Enhances NK Cell Effector and Memory-Like Functions by Increasing Interleukin-15-Mediated STAT Activation.
    J Virol. 2022 Jul 14:e0037222. doi: 10.1128/jvi.00372.
    PubMed     Abstract available


  15. BAKER EJ, Hughes K, Travieso T, Klotman ME, et al
    Establishment, Persistence, and Reactivation of Latent HIV-1 Infection in Renal Epithelial Cells.
    J Virol. 2022 Jul 5:e0062422. doi: 10.1128/jvi.00624.
    PubMed     Abstract available


  16. RATCLIFF AN, Venner CM, Olabode AS, Knapp J, et al
    Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope.
    J Virol. 2022 Jul 5:e0185121. doi: 10.1128/jvi.01851.
    PubMed     Abstract available


    June 2022
  17. HOFFMAN HK, Aguilar RS, Clark AR, Groves NS, et al
    Endocytosed HIV-1 Envelope Glycoprotein Traffics to Rab14(+) Late Endosomes and Lysosomes to Regulate Surface Levels in T-Cell Lines.
    J Virol. 2022 Jun 30:e0076722. doi: 10.1128/jvi.00767.
    PubMed     Abstract available


  18. KAO S, Miyagi E, Mallorson R, Saito H, et al
    The Myeloid-Specific Transcription Factor PU.1 Upregulates Mannose Receptor Expression but Represses Basal Activity of the HIV-LTR Promoter.
    J Virol. 2022 Jun 29:e0065222. doi: 10.1128/jvi.00652.
    PubMed     Abstract available


  19. AVILA-RIOS S, Garcia-Morales C, Reyes-Teran G, Gonzalez-Rodriguez A, et al
    Phylodynamics of HIV in the Mexico City Metropolitan Region.
    J Virol. 2022 Jun 28:e0070822. doi: 10.1128/jvi.00708.
    PubMed     Abstract available


  20. RICHETTA C, Subra F, Malet I, Leh H, et al
    Mutations in the 3'-PPT Lead to HIV-1 Replication without Integration.
    J Virol. 2022 Jun 27:e0067622. doi: 10.1128/jvi.00676.
    PubMed     Abstract available


  21. SHEWARD DJ, Hermanus T, Murrell B, Garrett N, et al
    HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies.
    J Virol. 2022 Jun 27:e0032422. doi: 10.1128/jvi.00324.
    PubMed     Abstract available


  22. PEDERSEN SF, Collora JA, Kim RN, Yang K, et al
    Inhibition of a Chromatin and Transcription Modulator, SLTM, Increases HIV-1 Reactivation Identified by a CRISPR Inhibition Screen.
    J Virol. 2022 Jun 22:e0057722. doi: 10.1128/jvi.00577.
    PubMed     Abstract available


  23. LIN J, Law R, Korosec CS, Zhou C, et al
    Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    J Virol. 2022 Jun 14:e0050922. doi: 10.1128/jvi.00509.
    PubMed     Abstract available


  24. JOSEPH KW, Halvas EK, Brandt LD, Patro SC, et al
    Deep Sequencing Analysis of Individual HIV-1 Proviruses Reveals Frequent Asymmetric Long Terminal Repeats.
    J Virol. 2022 Jun 8:e0012222. doi: 10.1128/jvi.00122.
    PubMed     Abstract available


  25. ROJAS CHAVEZ RA, Boyt D, Schwery N, Han C, et al
    Commonly Elicited Antibodies against the Base of the HIV-1 Env Trimer Guide the Population-Level Evolution of a Structure-Regulating Region in gp41.
    J Virol. 2022 Jun 6:e0040622. doi: 10.1128/jvi.00406.
    PubMed     Abstract available


    May 2022
  26. KLEINMAN AJ, Sivanandham S, Sette P, Sivanandham R, et al
    Changes to the Simian Immunodeficiency Virus (SIV) Reservoir and Enhanced SIV-Specific Responses in a Rhesus Macaque Model of Functional Cure after Serial Rounds of Romidepsin Administrations.
    J Virol. 2022 May 31:e0044522. doi: 10.1128/jvi.00445.
    PubMed     Abstract available


  27. PETERS RJ, Stevenson M
    Irreversible Loss of HIV-1 Proviral Competence in Myeloid Cells upon Suppression of NF-kappaB Activity.
    J Virol. 2022 May 23:e0048422. doi: 10.1128/jvi.00484.
    PubMed     Abstract available


  28. PEI Z, Wang H, Zhao Z, Chen X, et al
    Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage.
    J Virol. 2022 May 17:e0043522. doi: 10.1128/jvi.00435.
    PubMed     Abstract available


  29. TU JJ, Kumar A, Giorgi EE, Eudailey J, et al
    Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
    J Virol. 2022 May 10:e0023122. doi: 10.1128/jvi.00231.
    PubMed     Abstract available


  30. SACKS D, Wiehe K, Morris L, Moore PL, et al
    Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.
    J Virol. 2022 May 5:e0027022. doi: 10.1128/jvi.00270.
    PubMed     Abstract available


  31. BUTTA GM, Bozzi G, Gallo G, Copaloni G, et al
    Heterogeneity of Latency Establishment in the Different Human CD4(+) T Cell Subsets Stimulated with IL-15.
    J Virol. 2022 May 2:e0037922. doi: 10.1128/jvi.00379.
    PubMed     Abstract available


    April 2022
  32. CIENIEWICZ B, Kirillov V, Daher I, Li X, et al
    IKKalpha-Mediated Noncanonical NF-kappaB Signaling Is Required To Support Murine Gammaherpesvirus 68 Latency In Vivo.
    J Virol. 2022 Apr 28:e0002722. doi: 10.1128/jvi.00027.
    PubMed     Abstract available


  33. CHIKATA T, Paes W, Kuse N, Partridge T, et al
    Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
    J Virol. 2022 Apr 27:e0043222. doi: 10.1128/jvi.00432.
    PubMed     Abstract available


  34. TABLER CO, Wegman SJ, Chen J, Shroff H, et al
    The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release.
    J Virol. 2022 Apr 19:e0219821. doi: 10.1128/jvi.02198.
    PubMed     Abstract available


  35. RESOP RS, Bosque A
    Pharmacological Targeting of Sphingosine Kinases Impedes HIV-1 Infection of CD4 T Cells through SAMHD1 Modulation.
    J Virol. 2022 Apr 12:e0009622. doi: 10.1128/jvi.00096.
    PubMed     Abstract available


  36. KLASSE PJ, Moore JP
    Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
    J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
    PubMed     Abstract available


    March 2022
  37. NGUYEN HT, Qualizza A, Anang S, Zhao M, et al
    Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.
    J Virol. 2022 Mar 28:e0166821. doi: 10.1128/jvi.01668.
    PubMed     Abstract available


  38. LU F, Zankharia U, Vladimirova O, Yi Y, et al
    Epigenetic Landscape of HIV-1 Infection in Primary Human Macrophage.
    J Virol. 2022 Mar 23:e0016222. doi: 10.1128/jvi.00162.
    PubMed     Abstract available


  39. HOTZEL I
    Deep-Time Structural Evolution of Retroviral and Filoviral Surface Envelope Proteins.
    J Virol. 2022 Mar 23:e0006322. doi: 10.1128/jvi.00063.
    PubMed     Abstract available


  40. XIANG J, Lu M, Shi M, Cheng X, et al
    Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
    PubMed     Abstract available


  41. YERO A, Farnos O, Clain J, Zghidi-Abouzid O, et al
    Impact of Early ARV Initiation on Relative Proportions of Effector and Regulatory CD8 T Cell in Mesenteric Lymph Nodes and Peripheral Blood During Acute SIV Infection of Rhesus Macaques.
    J Virol. 2022 Mar 21:e0025522. doi: 10.1128/jvi.00255.
    PubMed     Abstract available


  42. COGSWELL A, Jo S, Ferguson N, Gupta K, et al
    Presence of Natural Killer B Cells in Simian Immunodeficiency Virus-Infected Colon That Have Properties and Functions Similar to Those of Natural Killer Cells and B Cells but Are a Distinct Cell Population.
    J Virol. 2022 Mar 21:e0023522. doi: 10.1128/jvi.00235.
    PubMed     Abstract available


  43. ANWAR A, Helou M, Hervol J, Levine AD, et al
    Impact of Caveolin-Mediated Endocytosis on the Trafficking of HIV within the Colonic Barrier.
    J Virol. 2022 Mar 17:e0020222. doi: 10.1128/jvi.00202.
    PubMed     Abstract available


  44. CHEN SMY, Wong YC, Yim LY, Zhang H, et al
    Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
    J Virol. 2022 Mar 17:e0216121. doi: 10.1128/jvi.02161.
    PubMed     Abstract available


  45. BRICKER KM, Obregon-Perko V, Williams B, Oliver D, et al
    Altered Response Pattern following AZD5582 Treatment of SIV-Infected, ART-Suppressed Rhesus Macaque Infants.
    J Virol. 2022 Mar 16:e0169921. doi: 10.1128/jvi.01699.
    PubMed     Abstract available


  46. WANG Q, Esnault F, Zhao M, Chiu TJ, et al
    Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.
    J Virol. 2022 Mar 15:e0187821. doi: 10.1128/jvi.01878.
    PubMed     Abstract available


  47. CARLIN E, Greer B, Lowman K, Dalecki AG, et al
    Lentiviral Nef Proteins Differentially Govern the Establishment of Viral Latency.
    J Virol. 2022 Mar 10:e0220621. doi: 10.1128/jvi.02206.
    PubMed     Abstract available


    February 2022
  48. FISHER K, Wang XQ, Lee A, Morcilla V, et al
    Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes.
    J Virol. 2022 Feb 24:jvi0201121. doi: 10.1128/jvi.02011.
    PubMed     Abstract available


  49. ELSAYED H, Nabi G, McKinstry WJ, Khoo KK, et al
    Correction for Elsayed et al., "Intrastructural Help: Harnessing T Helper Cells Induced by Licensed Vaccines for Improvement of HIV Env Antibody Responses to Virus-Like Particle Vaccines".
    J Virol. 2022;96:e0195421.
    PubMed    


  50. MIKI S, Kawai Y, Nakayama-Hosoya K, Iwabuchi R, et al
    Sustainable antiviral efficacy of rejuvenated HIV-specific cytotoxic T lymphocytes generated from induced pluripotent stem cells.
    J Virol. 2022 Feb 2:jvi0221721. doi: 10.1128/jvi.02217.
    PubMed     Abstract available


    January 2022
  51. PREVOST J, Richard J, Gasser R, Medjahed H, et al
    Detection of the HIV-1 accessory proteins Nef and Vpu by flow cytometry represents a new tool to study their functional interplay within a single infected CD4+ T cell.
    J Virol. 2022 Jan 26:jvi0192921. doi: 10.1128/jvi.01929.
    PubMed     Abstract available


  52. OHATA Y, Tomonaga M, Watanabe Y, Tomura K, et al
    Antiviral Activity and Resistance Profile of the Novel HIV-1 Non-Catalytic Site Integrase Inhibitor, JTP-0157602.
    J Virol. 2022 Jan 19:JVI0184321. doi: 10.1128/JVI.01843.
    PubMed     Abstract available


  53. RICHTER E, Bornemann L, Korencak M, Alter G, et al
    Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors.
    J Virol. 2022 Jan 12:JVI0173021. doi: 10.1128/JVI.01730.
    PubMed     Abstract available


  54. DALECKI AG, Greer BD, Duverger A, Strange EL, et al
    Host T cell dedifferentiation effects drive HIV-1 latency stability.
    J Virol. 2022 Jan 12:jvi0197421. doi: 10.1128/jvi.01974.
    PubMed     Abstract available


    December 2021
  55. VAN DORSTEN RT, Reh L, Trkola A, Morris L, et al
    Single-chain variable fragments of broadly neutralizing antibodies prevent HIV cell-cell transmission.
    J Virol. 2021 Dec 22:jvi0193421. doi: 10.1128/jvi.01934.
    PubMed     Abstract available


  56. ETTICH J, Werner J, Weitz HT, Mueller E, et al
    A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
    J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
    PubMed     Abstract available


  57. CHESARINO NM, Emerman M
    HIV-1 Vif gained breadth in APOBEC3G specificity after cross-species transmission of its precursors.
    J Virol. 2021 Dec 15:JVI0207121. doi: 10.1128/JVI.02071.
    PubMed     Abstract available


  58. HANY L, Turmel MO, Barat C, Ouellet M, et al
    Bryostatin-1 decreases HIV-1 infection and viral production in human primary macrophages.
    J Virol. 2021 Dec 8:JVI0195321. doi: 10.1128/JVI.01953.
    PubMed     Abstract available


  59. YAO W, Strebel K, Yamaoka S, Yoshida T, et al
    SIVgsn-99CM71 Vpu employs different amino acids to antagonize human and greater spot-nosed monkey BST-2.
    J Virol. 2021 Dec 8:JVI0152721. doi: 10.1128/JVI.01527.
    PubMed     Abstract available


    November 2021
  60. HOLGUIN L, Echavarria L, Burnetta JC
    Novel humanized-PBMC mouse model with delayed onset of GVHD for preclinical HIV research.
    J Virol. 2021 Nov 24:JVI0139421. doi: 10.1128/JVI.01394.
    PubMed     Abstract available


  61. WU C, He Y, Zhao J, Luo K, et al
    Exacerbated AIDS progression by PD-1 blockade during therapeutic vaccination in chronically SIV-infected rhesus macaques after ART treatment interruption.
    J Virol. 2021 Nov 24:JVI0178521. doi: 10.1128/JVI.01785.
    PubMed     Abstract available


  62. BELLON M, Nicot C
    Feedback Loop Regulation Between Pim Kinases and Tax Keeps HTLV-I Viral Replication in Check.
    J Virol. 2021 Nov 24:JVI0196021. doi: 10.1128/JVI.01960.
    PubMed     Abstract available


  63. ALVARADO-HERNANDEZ B, Ma Y, Sharma NR, Majerciak V, et al
    Protein-RNA interactome analysis reveals wide association of KSHV ORF57 with host non-coding RNAs and polysomes.
    J Virol. 2021 Nov 17:JVI0178221. doi: 10.1128/JVI.01782.
    PubMed     Abstract available


  64. HEMSATH JR, Liaci AM, Rubin JD, Parrett BJ, et al
    Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26).
    J Virol. 2021 Nov 17:JVI0082621. doi: 10.1128/JVI.00826.
    PubMed     Abstract available


  65. VIEIRA VA, Adland E, Grayson NE, Csala A, et al
    Two distinct mechanisms leading to loss of virological control in the rare group of antiretroviral therapy-naive, transiently aviraemic children living with HIV.
    J Virol. 2021 Nov 10:JVI0153521. doi: 10.1128/JVI.01535.
    PubMed     Abstract available


  66. CHEN J, Zhao S, Cui Z, Li W, et al
    MicroRNA-376b-3p Promotes Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Restriction Factor TRIM22.
    J Virol. 2021 Nov 10:JVI0159721. doi: 10.1128/JVI.01597.
    PubMed     Abstract available


  67. WANG XF, Wang YH, Bai B, Zhang M, et al
    Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.
    J Virol. 2021;95:e0108721.
    PubMed     Abstract available


  68. DUGGAN NN, Weisgrau KL, Magnani DM, Rakasz EG, et al
    SOSIP trimer-specific antibodies isolated from a SHIV-infected monkey with versus without a pre-blocking step with gp41.
    J Virol. 2021 Nov 3:JVI0158221. doi: 10.1128/JVI.01582.
    PubMed     Abstract available


  69. MIELKE D, Stanfield-Oakley S, Borate B, Fisher LH, et al
    Selection of HIV Envelope strains for standardized assessments of vaccine-elicited antibody-dependent cellular cytotoxicity (ADCC)-mediating antibodies.
    J Virol. 2021 Nov 3:JVI0164321. doi: 10.1128/JVI.01643.
    PubMed     Abstract available


  70. GACH JS, Matsuno SY, Mercado M, Hangartner L, et al
    Internalization of HIV-1 by phagocytes is increased when virions are opsonized with multimeric antibody in the presence of complement.
    J Virol. 2021 Nov 3:JVI0168921. doi: 10.1128/JVI.01689.
    PubMed     Abstract available


  71. ZHAO Y, Du J, Wang Y, Wang Q, et al
    BST2 suppresses LINE-1 retrotransposition by reducing the promoter activity of LINE-1 5'-UTR.
    J Virol. 2021 Nov 3:JVI0161021. doi: 10.1128/JVI.01610.
    PubMed     Abstract available


    October 2021
  72. YU J, Collins ND, Mercado NB, McMahan K, et al
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
    PubMed     Abstract available


  73. HOTZEL I
    Domain Organization of Lentiviral and Betaretroviral Surface Envelope Glycoproteins Modeled with AlphaFold.
    J Virol. 2021 Oct 27:JVI0134821. doi: 10.1128/JVI.01348.
    PubMed     Abstract available


  74. SCHORCHT A, Cottrell CA, Pugach P, Ringe RP, et al
    The glycan hole area of HIV-1 envelope trimers contributes prominently to the induction of autologous neutralization.
    J Virol. 2021 Oct 20:JVI0155221. doi: 10.1128/JVI.01552.
    PubMed     Abstract available


  75. COLOMER-LLUCH M, Kilpelainen A, Pernas M, Pena R, et al
    Viral and Cellular factors leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.
    J Virol. 2021 Oct 20:JVI0149921. doi: 10.1128/JVI.01499.
    PubMed     Abstract available


  76. BELTRAN-PAVEZ C, Bontjer I, Gonzalez N, Pernas M, et al
    Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle (VLP) Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
    J Virol. 2021 Oct 20:JVI0134321. doi: 10.1128/JVI.01343.
    PubMed     Abstract available


  77. CACCURI F, Neves V, Gano L, Correia JDG, et al
    The HIV-1 matrix protein p17 does cross the Blood-Brain Barrier.
    J Virol. 2021 Oct 20:JVI0120021. doi: 10.1128/JVI.01200.
    PubMed     Abstract available


  78. BENNER BE, Bruce JW, Kentala JR, Murray M, et al
    Perturbing HIV-1 ribosomal frameshifting frequency reveals a cis preference for Gag-Pol incorporation into assembling virions.
    J Virol. 2021 Oct 13:JVI0134921. doi: 10.1128/JVI.01349.
    PubMed     Abstract available


  79. BALAMURUGAN A, Ng HL, Yang OO
    Correction for Balamurugan et al., "Cross-Reactivity against Multiple HIV-1 Epitopes Is Characteristic of HIV-1-Specific Cytotoxic T Lymphocyte Clones".
    J Virol. 2021;95:e0139721.
    PubMed    


  80. SOWD GA, Shi J, Aiken C
    HIV-1 CA inhibitors are antagonized by inositol phosphate stabilization of the viral capsid in cells.
    J Virol. 2021 Oct 6:JVI0144521. doi: 10.1128/JVI.01445.
    PubMed     Abstract available


  81. KURNAEVA MA, Zalevsky AO, Arifulin EA, Lisitsyna OM, et al
    Molecular coevolution of nuclear and nucleolar localization signals inside basic domain of HIV-1 Tat.
    J Virol. 2021 Oct 6:JVI0150521. doi: 10.1128/JVI.01505.
    PubMed     Abstract available


    September 2021
  82. NAGEL L, Kant S, Leeks C, Routy JP, et al
    Evolution of antibodies to native trimeric envelope and their Fc dependent functions in untreated and treated primary HIV infection.
    J Virol. 2021 Sep 29:JVI0162521. doi: 10.1128/JVI.01625.
    PubMed     Abstract available


  83. TORRENTS DE LA PENA A, Del Moral Sanchez I, Burger JA, Bontjer I, et al
    Targeted destabilization of the HIV-1 gp120-gp41 interface leads to convergent evolution with mutations in the V1V2, HR1 and HR2 domains.
    J Virol. 2021 Sep 29:JVI0053221. doi: 10.1128/JVI.00532.
    PubMed     Abstract available


  84. LAI M, Maori E, Quaranta P, Matteoli G, et al
    CRISPR/Cas9 ablation of integrated HIV-1 accumulates proviral DNA circles with reformed LTRs.
    J Virol. 2021 Sep 22:JVI0135821. doi: 10.1128/JVI.01358.
    PubMed     Abstract available


  85. SMITH LM, Ladner JT, Hodara VL, Parodi LM, et al
    MULTIPLEXED SIV-SPECIFIC PAIRED RNA-GUIDED CAS9 NICKASES INACTIVATE PROVIRAL DNA.
    J Virol. 2021 Sep 22:JVI0088221. doi: 10.1128/JVI.00882.
    PubMed     Abstract available


  86. ZHANG S, Wang K, Wang WL, Nguyen HT, et al
    Asymmetric structures and conformational plasticity of the uncleaved full-length human immunodeficiency virus (HIV-1) envelope glycoprotein trimer.
    J Virol. 2021 Sep 22:JVI0052921. doi: 10.1128/JVI.00529.
    PubMed     Abstract available


  87. IMAMICHI T, Bernbaum JG, Laverdure S, Yang J, et al
    Natural Occurring Polymorphisms in HIV-1 Integrase and RNase H Regulate Viral Release and Autoprocessing.
    J Virol. 2021 Sep 15:JVI0132321. doi: 10.1128/JVI.01323.
    PubMed     Abstract available


  88. KUSE N, Murakoshi H, Akahoshi T, Chikata T, et al
    Collaboration of a detrimental HLA-B*35:01 allele with HLA-A*24:02 in co-evolution of HIV-1 with T-cells leading to poorer clinical outcomes.
    J Virol. 2021 Sep 15:JVI0125921. doi: 10.1128/JVI.01259.
    PubMed     Abstract available


  89. BANDARRA S, Miyagi E, Ribeiro AC, Goncalves J, et al
    APOBEC3B potently restricts HIV-2 but not HIV-1 in a Vif-dependent manner.
    J Virol. 2021 Sep 15:JVI0117021. doi: 10.1128/JVI.01170.
    PubMed     Abstract available


  90. ZHONG C, Liu F, Hajnik RJ, Yao L, et al
    Type-I IFN promotes humoral immunity in viral vector vaccination.
    J Virol. 2021 Sep 8:JVI0092521. doi: 10.1128/JVI.00925.
    PubMed     Abstract available


  91. ROSE R, Gonzalez-Perez MP, Nolan DJ, Cross S, et al
    Ultradeep HIV-1 proviral envelope sequencing reveals complex population structure within and between brain and splenic tissues.
    J Virol. 2021 Sep 8:JVI0120221. doi: 10.1128/JVI.01202.
    PubMed     Abstract available


    August 2021
  92. BRETON Y, Barat C, Tremblay MJ
    The balance between p53 isoforms modulates the efficiency of HIV-1 infection in macrophages.
    J Virol. 2021 Aug 11:JVI0118821. doi: 10.1128/JVI.01188.
    PubMed     Abstract available


  93. NCHIOUA R, Kmiec D, Gaba A, Sturzel CM, et al
    APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans.
    J Virol. 2021;95:e0080821.
    PubMed     Abstract available


    July 2021
  94. RAHMAN K, Compton AA
    The indirect antiviral potential of long non-coding RNAs encoded by IFITM pseudogenes.
    J Virol. 2021 Jul 28:JVI0068021. doi: 10.1128/JVI.00680.
    PubMed     Abstract available


  95. RICANA CL, Johnson MC
    An infectious Rous Sarcoma Virus Gag mutant that is defective in nuclear cycling.
    J Virol. 2021 Jul 28:JVI0064821. doi: 10.1128/JVI.00648.
    PubMed     Abstract available


  96. MARIC D, Grimm WA, Greco N, McRaven MD, et al
    Th17 T cells and immature dendritic cells are the preferential initial targets after rectal challenge with an SIV-based replication-defective dual-reporter vector.
    J Virol. 2021 Jul 21:JVI0070721. doi: 10.1128/JVI.00707.
    PubMed     Abstract available


  97. WONG ME, Johnson CJ, Hearps AC, Jaworowski A, et al
    Development of a novel in vitro primary human monocyte-derived macrophage model to study reactivation of HIV-1 transcription.
    J Virol. 2021 Jul 21:JVI0022721. doi: 10.1128/JVI.00227.
    PubMed     Abstract available


  98. BUCKMASTER MV, Zadrozny KK, Ganser-Pornillos BK, Pornillos O, et al
    Structural determinants of virion assembly and release in the C-terminus of the M-PMV capsid protein.
    J Virol. 2021 Jul 21:JVI0061521. doi: 10.1128/JVI.00615.
    PubMed     Abstract available


  99. SPERK M, Ambikan AT, Ray S, Singh K, et al
    Fecal metabolome signature in HIV-1 elite control phenotype: Enrichment of dipeptides act as HIV-1 antagonist but Prevotella agonist.
    J Virol. 2021 Jul 7:JVI0047921. doi: 10.1128/JVI.00479.
    PubMed     Abstract available


  100. SUFIAWATI I, Herrera R, Mayer W, Cai X, et al
    Human immunodeficiency virus and human cytomegalovirus coinfection of infant tonsil epithelium may synergistically promote both HIV-1 and HCMV spread and infection.
    J Virol. 2021 Jul 7:JVI0092121. doi: 10.1128/JVI.00921.
    PubMed     Abstract available


  101. ANAND SP, Ding S, Tolbert WD, Prevost J, et al
    Enhanced ability of plant-derived PGT121 glycovariants to eliminate HIV-1-infected cells.
    J Virol. 2021 Jul 7:JVI0079621. doi: 10.1128/JVI.00796.
    PubMed     Abstract available


  102. ROY CN, Benitez Moreno MA, Kline C, Ambrose Z, et al
    CG dinucleotide removal in bioluminescent and fluorescent reporters improves HIV-1 replication and reporter gene expression for dual imaging in humanized mice.
    J Virol. 2021 Jul 7:JVI0044921. doi: 10.1128/JVI.00449.
    PubMed     Abstract available


    June 2021
  103. TAN TS, Toyoda M, Tokunaga K, Ueno T, et al
    Aromatic side chain at position 412 of SERINC5 exerts restriction activity toward HIV-1 and other retroviruses.
    J Virol. 2021 Jun 30:JVI0063421. doi: 10.1128/JVI.00634.
    PubMed     Abstract available


  104. ROSENBERG YJ, Jiang X, Cheever T, Coulter FJ, et al
    Protection of newborn macaques by plant-derived HIV broadly neutralizing antibodies: a model for passive immunotherapy during breastfeeding.
    J Virol. 2021 Jun 30:JVI0026821. doi: 10.1128/JVI.00268.
    PubMed     Abstract available


  105. MARZIALI F, Delpeuch M, Kumar A, Appourchaux R, et al
    Functional heterogeneity of mammalian IFITM proteins against HIV-1.
    J Virol. 2021 Jun 23:JVI0043921. doi: 10.1128/JVI.00439.
    PubMed     Abstract available


  106. LI Y, Bai H, Sanders-Buell E, Dussupt V, et al
    Limited evidence for a relationship between HIV-1 glycan shield features in early infection and the development of neutralization breadth.
    J Virol. 2021 Jun 23:JVI0079721. doi: 10.1128/JVI.00797.
    PubMed     Abstract available


  107. DUAN S, Xu X, Wang J, Huang L, et al
    TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4(+) T Cells.
    J Virol. 2021 Jun 16:JVI0081621. doi: 10.1128/JVI.00816.
    PubMed     Abstract available


  108. KRUMP NA, Wang R, Liu W, Yang JF, et al
    Merkel Cell Polyomavirus Infection Induces an Antiviral Innate Immune Response in Human Dermal Fibroblasts.
    J Virol. 2021;95:e0221120.
    PubMed     Abstract available


  109. WANAGURU M, Bishop KN
    HIV-1 Gag recruits oligomeric Vpr via two binding sites in p6, but both mature p6 and Vpr are rapidly lost upon target cell entry.
    J Virol. 2021 Jun 9:JVI0055421. doi: 10.1128/JVI.00554.
    PubMed     Abstract available


  110. PRICEPUTU E, Cool M, Bouchard N, Caceres-Cortes JR, et al
    HIV-1 Nef induces Hck/Lyn-dependent expansion of MDSC associated with elevated IL-17/G-CSF.
    J Virol. 2021 Jun 9:JVI0047121. doi: 10.1128/JVI.00471.
    PubMed     Abstract available


  111. DAVIDS BO, Balasubramaniam M, Sapp N, Prakash P, et al
    Human Three Prime Repair Exonuclease 1 Promotes HIV-1 Integration by Preferentially Degrading Unprocessed Viral DNA.
    J Virol. 2021 Jun 9:JVI0055521. doi: 10.1128/JVI.00555.
    PubMed     Abstract available


  112. VAN HAAREN MM, McCoy LE, Torres JL, Lee W, et al
    Antibodies from rabbits immunized with HIV-1 clade B SOSIP trimers can neutralize multiple clade B viruses by destabilizing the envelope glycoprotein.
    J Virol. 2021 Jun 2:JVI0009421. doi: 10.1128/JVI.00094.
    PubMed     Abstract available


  113. ALSULAMI K, Bolastig N, Dupuy FP, Mabanga T, et al
    Influence of NKG2C Genotypes on HIV Susceptibility and Viral Load Set Point.
    J Virol. 2021 Jun 2:JVI0041721. doi: 10.1128/JVI.00417.
    PubMed     Abstract available


  114. QIN K, Boppana S, Carlson JM, Fiore-Gartland A, et al
    Elevated HIV infection of CD4 T cells in MRKAd5 vaccine recipients due to CD8 T cells targeting of adapted epitopes.
    J Virol. 2021 Jun 2:JVI0016021. doi: 10.1128/JVI.00160.
    PubMed     Abstract available


  115. LUO MT, Mu D, Yang X, Luo RH, et al
    Tree shrew cells transduced with human CD4 and CCR5 support early steps of HIV-1 replication, but viral infectivity is restricted by APOBEC3.
    J Virol. 2021 Jun 2:JVI0002021. doi: 10.1128/JVI.00020.
    PubMed     Abstract available


  116. NAKAJIMA S, Watashi K, Kato T, Muramatsu M, et al
    Biochemical and structural properties of entecavir-resistant hepatitis B virus polymerase with L180M/M204V mutations.
    J Virol. 2021 Jun 2:JVI0240120. doi: 10.1128/JVI.02401.
    PubMed     Abstract available


  117. KUSE N, Akahoshi T, Takiguchi M
    STING ligand-mediated priming of functional CD8(+) T-cells specific for HIV-1 protective epitopes from naive T-cells.
    J Virol. 2021 Jun 2:JVI0069921. doi: 10.1128/JVI.00699.
    PubMed     Abstract available


    May 2021
  118. MUMBY MJ, Johnson AL, Trothen SM, Edgar CR, et al
    An amino acid polymorphism within the HIV-1 Nef dileucine motif functionally uncouples cell surface CD4 and SERINC5 downregulation.
    J Virol. 2021 May 26:JVI0058821. doi: 10.1128/JVI.00588.
    PubMed     Abstract available


  119. AO Z, Wang L, Azizi H, Abiola TO, et al
    Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New DC-Targeting Vaccine Approach Against HIV-1.
    J Virol. 2021 May 19. pii: JVI.02368-20. doi: 10.1128/JVI.02368.
    PubMed     Abstract available


  120. FERREIRA BARBOSA JA, Sparapani S, Boulais J, Lodge R, et al
    Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.
    J Virol. 2021 May 19. pii: JVI.00971-20. doi: 10.1128/JVI.00971.
    PubMed     Abstract available


  121. OSTERMANN PN, Ritchie A, Ptok J, Schaal H, et al
    Let it go: HIV-1 cis-acting repressive sequences.
    J Virol. 2021 May 12. pii: JVI.00342-21. doi: 10.1128/JVI.00342.
    PubMed     Abstract available


  122. PIETRANTONI G, Gaete-Argel A, Herrera-Rojo D, Ibarra-Karmy R, et al
    Dynein light chain Dynlrb2 is essential for Murine leukemia virus traffic and nuclear entry.
    J Virol. 2021 May 12. pii: JVI.00170-21. doi: 10.1128/JVI.00170.
    PubMed     Abstract available


  123. REN Y, Huang SH, Macedo AB, Ward AR, et al
    Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary Cell Model of HIV Latency but not from Ex Vivo Reservoirs.
    J Virol. 2021 May 12. pii: JVI.02425-20. doi: 10.1128/JVI.02425.
    PubMed     Abstract available


  124. RUBIO AA, Filsinger Interrante MV, Bell BN, Brown CL, et al
    A derivative of the D5 monoclonal antibody that targets the gp41 N-heptad repeat of HIV-1 with broad tier-2 neutralizing activity.
    J Virol. 2021 May 12. pii: JVI.02350-20. doi: 10.1128/JVI.02350.
    PubMed     Abstract available


  125. TAUZIN A, Ortiz AE, Blake O, Soundaramourty C, et al
    Differential inhibition of HIV replication by the 12 interferon-alpha subtypes.
    J Virol. 2021 May 12. pii: JVI.02311-20. doi: 10.1128/JVI.02311.
    PubMed     Abstract available


  126. HORMAN WSJ, Kedzierska K, Rootes CL, Bean AGD, et al
    Upregulated expression of ferret Interferon-Inducible Transmembrane genes by IFN-alpha and influenza virus infection.
    J Virol. 2021 May 5. pii: JVI.00111-21. doi: 10.1128/JVI.00111.
    PubMed     Abstract available


  127. PASSAES C, Delagreverie HM, Avettand-Fenoel V, David A, et al
    Ultrasensitive detection of p24 in plasma samples from people with primary and chronic HIV-1 infection.
    J Virol. 2021 May 5. pii: JVI.00016-21. doi: 10.1128/JVI.00016.
    PubMed     Abstract available


    April 2021
  128. CASTRO IM, Ricciardi MJ, Gonzalez-Nieto L, Rakasz EG, et al
    Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection Against SIVmac239 Acquisition
    J Virol. 2021 Apr 28. pii: JVI.00330-21. doi: 10.1128/JVI.00330.
    PubMed     Abstract available


  129. KOMA T, Yokoyama M, Kotani O, Doi N, et al
    Species-specific valid ternary interactions of HIV-1 Env-gp120, CD4, and CCR5 as revealed by an adaptive single-amino acid substitution at the V3 loop tip.
    J Virol. 2021 Apr 21. pii: JVI.02177-20. doi: 10.1128/JVI.02177.
    PubMed     Abstract available


  130. LEAMAN DP, Stano A, Chen Y, Zhang L, et al
    Membrane Env liposomes facilitate immunization with multivalent full-length HIV spikes.
    J Virol. 2021 Apr 21. pii: JVI.00005-21. doi: 10.1128/JVI.00005.
    PubMed     Abstract available


  131. RAMDAS P, Bhardwaj V, Singh A, Vijay N, et al
    Coelacanth SERINC2 inhibits HIV-1 infectivity and is counteracted by envelope glycoprotein from foamy virus.
    J Virol. 2021 Apr 21. pii: JVI.00229-21. doi: 10.1128/JVI.00229.
    PubMed     Abstract available


  132. IRWAN ID, Cullen BR
    Tax induces the recruitment of NF-kB to unintegrated HIV-1 DNA to rescue viral gene expression and replication.
    J Virol. 2021 Apr 21. pii: JVI.00285-21. doi: 10.1128/JVI.00285.
    PubMed     Abstract available


  133. EDWARDS JM, Heydarchi B, Khoury G, Salazar-Quiroz NA, et al
    Enhancement of antibody-dependent cellular cytotoxicity and phagocytosis in anti-HIV-1 bovine chimeric broadly-neutralizing antibodies.
    J Virol. 2021 Apr 14. pii: JVI.00219-21. doi: 10.1128/JVI.00219.
    PubMed     Abstract available


  134. LIU Q, Zhang P, Miao H, Lin Y, et al
    Rational engraftment of quaternary-interactive acidic loops for anti-HIV-1 antibody improvement.
    J Virol. 2021 Apr 7. pii: JVI.00159-21. doi: 10.1128/JVI.00159.
    PubMed     Abstract available


  135. GAO W, Li G, Zhao S, Wang H, et al
    Deubiquitinating enzyme USP21 inhibits HIV-1 replication by downregulating Tat expression.
    J Virol. 2021 Apr 7. pii: JVI.00460-21. doi: 10.1128/JVI.00460.
    PubMed     Abstract available


  136. ALTO A, Natesampillai S, Chandrasekar AP, Krogman A, et al
    The combination of venetoclax and ixazomib selectively and efficiently kills HIV infected cell lines, but has unacceptable toxicity in primary cell models.
    J Virol. 2021 Apr 7. pii: JVI.00138-21. doi: 10.1128/JVI.00138.
    PubMed     Abstract available


    March 2021
  137. URIU K, Kosugi Y, Suzuki N, Ito J, et al
    Elucidation of the complicated scenario of primate APOBEC3 gene evolution.
    J Virol. 2021 Mar 31. pii: JVI.00144-21. doi: 10.1128/JVI.00144.
    PubMed     Abstract available


  138. WANG J, Shu T, Deng W, Zheng Y, et al
    Mucosal priming with a recombinant influenza A virus-vectored vaccine elicits T-cell and antibody responses to HIV-1 in mice.
    J Virol. 2021 Mar 31. pii: JVI.00059-21. doi: 10.1128/JVI.00059.
    PubMed     Abstract available


  139. CERIANI C, Streeter GS, Lemu KJ, James KS, et al
    Defining stable reference genes in HIV latency reversal experiments.
    J Virol. 2021 Mar 24. pii: JVI.02305-20. doi: 10.1128/JVI.02305.
    PubMed     Abstract available


  140. GAO H, Ozanturk AN, Wang Q, Harlan GH, et al
    Evaluation of HIV-1 latency reversal and antibody-dependent viral clearance by quantification of singly spliced HIV-1 vpu/env mRNA.
    J Virol. 2021 Mar 24. pii: JVI.02124-20. doi: 10.1128/JVI.02124.
    PubMed     Abstract available


  141. LEIS J, Luan CH, Audia JE, Dunne SF, et al
    Ilaprazole and other novel prazole-based compounds that bind Tsg101 inhibit viral budding of HSV-1/2 and HIV from cells.
    J Virol. 2021 Mar 17. pii: JVI.00190-21. doi: 10.1128/JVI.00190.
    PubMed     Abstract available


  142. LUO Z, Li M, Mi F, Meng Z, et al
    A link between IL-23 and anti-CD4 autoantibody production in antiretroviral-treated HIV-infected individuals.
    J Virol. 2021 Mar 17. pii: JVI.00271-21. doi: 10.1128/JVI.00271.
    PubMed     Abstract available


  143. RANKOVIC S, Deshpande A, Harel S, Aiken C, et al
    HIV-1 uncoating occurs via a series of rapid biomechanical changes in the core related to individual stages of reverse transcription.
    J Virol. 2021 Mar 10. pii: JVI.00166-21. doi: 10.1128/JVI.00166.
    PubMed     Abstract available


  144. LI H, Wang S, Lee FH, Roark RS, et al
    New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure.
    J Virol. 2021 Mar 3. pii: JVI.00071-21. doi: 10.1128/JVI.00071.
    PubMed     Abstract available


  145. SUGAWARA S, El-Diwany R, Cohen LK, Rousseau KE, et al
    People with HIV-1 demonstrate type 1 interferon refractoriness associated with upregulated USP18.
    J Virol. 2021 Mar 3. pii: JVI.01777-20. doi: 10.1128/JVI.01777.
    PubMed     Abstract available


    February 2021
  146. LI W, Liu J, Liu Y, Li Q, et al
    HIV-1 uses dynamic podosomes for entry into macrophages.
    J Virol. 2021 Feb 24. pii: JVI.02480-20. doi: 10.1128/JVI.02480.
    PubMed     Abstract available


  147. ZHAO Z, Fagerlund R, Baur AS, Saksela K, et al
    HIV-1 Nef-induced secretion of the proinflammatory protease TACE into extracellularvesicles is mediated by Raf-1, and can be suppressed by clinical protein kinase inhibitors.
    J Virol. 2021 Feb 17. pii: JVI.00180-21. doi: 10.1128/JVI.00180.
    PubMed     Abstract available


  148. PIERINI V, Gallucci L, Sturzel CM, Kirchhoff F, et al
    SERINC5 can Enhance Pro-inflammatory Cytokine Production by Primary Human Myeloid Cells in Response to Challenge with HIV-1 Particles.
    J Virol. 2021 Feb 17. pii: JVI.02372-20. doi: 10.1128/JVI.02372.
    PubMed     Abstract available


  149. MAVIGNER M, Liao LE, Brooks AD, Ke R, et al
    CD8 lymphocyte depletion enhances the latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques.
    J Virol. 2021 Feb 10. pii: JVI.01429-20. doi: 10.1128/JVI.01429.
    PubMed     Abstract available


  150. LEVY Y, Lacabaratz C, Lhomme E, Wiedemann A, et al
    A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial.
    J Virol. 2021 Feb 10. pii: JVI.02165-20. doi: 10.1128/JVI.02165.
    PubMed     Abstract available


  151. ZIANI W, Bauer A, Lu H, Wang X, et al
    Immune responses and viral persistence in SHIV.C.CH848-infected rhesus macaques.
    J Virol. 2021 Feb 10. pii: JVI.02198-20. doi: 10.1128/JVI.02198.
    PubMed     Abstract available


  152. SANDSTROM TS, Ranganath N, Burke Schinkel SC, Salahuddin S, et al
    HIV-infected macrophages are infected and killed by the interferon-sensitive Rhabdovirus, MG1.
    J Virol. 2021 Feb 10. pii: JVI.01953-20. doi: 10.1128/JVI.01953.
    PubMed     Abstract available


  153. GRAMATICA A, Schwarzer R, Brantley W, Varco-Merth B, et al
    Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo.
    J Virol. 2021 Feb 3. pii: JVI.02393-20. doi: 10.1128/JVI.02393.
    PubMed     Abstract available


  154. PILKINTON MA, McDonnell WJ, Barnett L, Chopra A, et al
    In chronic infection, HIV gag-specific CD4+ T cell receptor diversity is higher than CD8+ T cell receptor diversity and is associated with less HIV quasispecies diversity.
    J Virol. 2021 Feb 3. pii: JVI.02380-20. doi: 10.1128/JVI.02380.
    PubMed     Abstract available


  155. ARACHCHIGE SP, Henke W, Kalamvoki M, Stephens EB, et al
    Structural Domains of the Herpes Simplex Type 1 gD Protein that Restrict HIV-1 Particle Infectivity.
    J Virol. 2021 Feb 3. pii: JVI.02355-20. doi: 10.1128/JVI.02355.
    PubMed     Abstract available


    January 2021
  156. MATSUI H, Shirakawa K, Konishi Y, Hirabayashi S, et al
    CAGE-seq reveals that HIV-1 latent infection does not trigger unique cellular responses in a Jurkat T cell model.
    J Virol. 2021 Jan 27. pii: JVI.02394-20. doi: 10.1128/JVI.02394.
    PubMed     Abstract available


  157. JANAKA SK, Palumbo AV, Tavakoli-Tameh A, Evans DT, et al
    Selective Disruption of SERINC5 Antagonism by Nef Impairs SIV Replication in Primary CD4(+) T Cells.
    J Virol. 2021 Jan 27. pii: JVI.01911-20. doi: 10.1128/JVI.01911.
    PubMed     Abstract available


  158. PUSNIK J, Fischinger S, Dittmer U, Esser S, et al
    Production of HIV-1 Env-specific antibodies mediating innate immune functions depends on cognate IL-21- secreting CD4+ T cells.
    J Virol. 2021 Jan 27. pii: JVI.02097-20. doi: 10.1128/JVI.02097.
    PubMed     Abstract available


  159. VIGLIANTI GA, Planelles V, Hanley TM
    Interactions with Commensal and Pathogenic Bacteria Induce HIV-1 Latency in Macrophages through Altered Transcription Factor Recruitment to the LTR.
    J Virol. 2021 Jan 20. pii: JVI.02141-20. doi: 10.1128/JVI.02141.
    PubMed     Abstract available


  160. MAYBERRY CL, Wilczek MP, Fong TM, Nichols SL, et al
    GRK2 mediates beta-arrestin interactions with 5-HT2 receptors for JC polyomavirus endocytosis.
    J Virol. 2021 Jan 13. pii: JVI.02139-20. doi: 10.1128/JVI.02139.
    PubMed     Abstract available


  161. SARABIA I, Huang SH, Ward AR, Jones RB, et al
    The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an In Vitro Primary TCM Cell Model of Latency.
    J Virol. 2021 Jan 13. pii: JVI.01297-20. doi: 10.1128/JVI.01297.
    PubMed     Abstract available


  162. MATSUOKA S, Kuwata T, Ishii H, Sekizuka T, et al
    A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus Macaques.
    J Virol. 2021 Jan 13. pii: JVI.02455-20. doi: 10.1128/JVI.02455.
    PubMed     Abstract available


  163. SANGARE K, Tuero I, Rahman MA, Hoang T, et al
    The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates.
    J Virol. 2021 Jan 13. pii: JVI.02253-20. doi: 10.1128/JVI.02253.
    PubMed     Abstract available


  164. ZIANI W, Shao J, Wang X, Russell-Lodrigue K, et al
    Increased proviral DNA in circulating cells correlates with plasma viral rebound in SIV-infected rhesus macaques after antiretroviral therapy interruption.
    J Virol. 2021 Jan 6. pii: JVI.02064-20. doi: 10.1128/JVI.02064.
    PubMed     Abstract available


    December 2020
  165. ZHANG Y, Murakoshi H, Chikata T, Akahoshi T, et al
    Effect of difference in consensus sequence between HIV-1 subtype A/E and subtype B viruses on elicitation of Gag-specific CD8(+) T cells and accumulation of HLA-associated escape mutations.
    J Virol. 2020 Dec 23. pii: JVI.02061-20. doi: 10.1128/JVI.02061.
    PubMed     Abstract available


  166. SANZ M, Madrid-Elena N, Serrano-Villar S, Vallejo A, et al
    Effect of the use of Galectin-9 and blockade of TIM-3 receptor in the latent cellular reservoir of HIV-1.
    J Virol. 2020 Dec 23. pii: JVI.02214-20. doi: 10.1128/JVI.02214.
    PubMed     Abstract available


  167. GAEBLER C, Falcinelli SD, Stoffel E, Read J, et al
    Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA.
    J Virol. 2020 Dec 23. pii: JVI.01986-20. doi: 10.1128/JVI.01986.
    PubMed     Abstract available


  168. ACHARYA A, Olwenyi OA, Thurman M, Pandey K, et al
    Chronic morphine administration differentially modulates viral reservoirs in SIVmac251 infected rhesus macaque model.
    J Virol. 2020 Dec 16. pii: JVI.01657-20. doi: 10.1128/JVI.01657.
    PubMed     Abstract available


  169. AKIYAMA H, Jalloh S, Park S, Lei M, et al
    Expression of HIV-1 Intron-Containing RNA in Microglia Induces Inflammatory Responses.
    J Virol. 2020 Dec 9. pii: JVI.01386-20. doi: 10.1128/JVI.01386.
    PubMed     Abstract available


  170. LORENZI JCC, Mendoza P, Cohen YZ, Nogueira L, et al
    Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates.
    J Virol. 2020 Dec 9. pii: JVI.01909-20. doi: 10.1128/JVI.01909.
    PubMed     Abstract available


  171. VEZINA D, Gong SY, Tolbert WD, Ding S, et al
    Stabilizing the HIV-1 envelope glycoprotein State 2A conformation.
    J Virol. 2020 Dec 9. pii: JVI.01620-20. doi: 10.1128/JVI.01620.
    PubMed     Abstract available


  172. DROUIN A, Migraine J, Durand MA, Moreau A, et al
    Escape of HIV-1 envelope glycoprotein from the restriction of infection by IFITM3.
    J Virol. 2020 Dec 9. pii: JVI.01994-20. doi: 10.1128/JVI.01994.
    PubMed     Abstract available


    November 2020
  173. MORI L, Jenike K, Yeh YJ, Lacombe B, et al
    The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency.
    J Virol. 2020 Nov 25. pii: JVI.01247-20. doi: 10.1128/JVI.01247.
    PubMed     Abstract available


  174. KLEIN K, Nankya I, Nickel G, Ratcliff AN, et al
    Deep gene sequence cluster analyses of multi-virus infected mucosal tissue reveal enhanced transmission of acute HIV-1.
    J Virol. 2020 Nov 11. pii: JVI.01737-20. doi: 10.1128/JVI.01737.
    PubMed     Abstract available


  175. ESPADA CE, St Gelais C, Bonifati S, Maksimova VV, et al
    TRAF6 and TAK1 contribute to SAMHD1-mediated negative regulation of NF-kappaB signaling.
    J Virol. 2020 Nov 11. pii: JVI.01970-20. doi: 10.1128/JVI.01970.
    PubMed     Abstract available


  176. BERENDAM SJ, Styles TM, Morgan-Asiedu PK, Tenney D, et al
    Systematic assessment of antiviral potency, breadth, and synergy of triple broadly neutralizing antibody combinations against Simian-Human Immunodeficiency Viruses.
    J Virol. 2020 Nov 11. pii: JVI.01667-20. doi: 10.1128/JVI.01667.
    PubMed     Abstract available


  177. REED JC, Solas D, Kitaygorodskyy A, Freeman B, et al
    Identification of an antiretroviral small molecule that appears to be a host-targeting inhibitor of HIV-1 assembly.
    J Virol. 2020 Nov 4. pii: JVI.00883-20. doi: 10.1128/JVI.00883.
    PubMed     Abstract available


  178. ZHANG S, Nguyen HT, Ding H, Wang J, et al
    Dual pathways of human immunodeficiency virus (HIV-1) envelope glycoprotein trafficking modulate the selective exclusion of uncleaved oligomers from virions.
    J Virol. 2020 Nov 4. pii: JVI.01369-20. doi: 10.1128/JVI.01369.
    PubMed     Abstract available


    October 2020
  179. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    PubMed     Abstract available


  180. REN Y, Korom M, Ward AR, Truong R, et al
    Relationships between Neutralization, Binding, and ADCC of Broadly Neutralizing Antibodies against Reservoir HIV.
    J Virol. 2020 Oct 28. pii: JVI.01808-20. doi: 10.1128/JVI.01808.
    PubMed     Abstract available


  181. ESCHBACH JE, Elliott JL, Li W, Zadrozny KK, et al
    Capsid lattice destabilization leads to premature loss of the viral genome and integrase enzyme during HIV-1 infection.
    J Virol. 2020 Oct 28. pii: JVI.00984-20. doi: 10.1128/JVI.00984.
    PubMed     Abstract available


  182. YUKL SA, Khan S, Chen TH, Trapecar M, et al
    Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103+ and Gut CD4+ T Cells.
    J Virol. 2020 Oct 28. pii: JVI.01331-20. doi: 10.1128/JVI.01331.
    PubMed     Abstract available


  183. ELENA GOMEZ C, Perdiguero B, Falqui M, Quiros M, et al
    Enhancement of HIV-1 Env-specific CD8 T cell responses using IFN-Stimulated Gene 15 (ISG15) as an immune adjuvant.
    J Virol. 2020 Oct 28. pii: JVI.01155-20. doi: 10.1128/JVI.01155.
    PubMed     Abstract available


  184. LU M, Ma X, Reichard N, Terry DS, et al
    Correction for Lu et al., "Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands".
    J Virol. 2020;94.
    PubMed    


  185. DEVASUNDARAM S, Rosati M, Valentin A, Weiss S, et al
    Priming with DNA expressing trimeric HIV V1V2 alters the immune hierarchy favoring the development of V2-specific antibodies in rhesus macaques.
    J Virol. 2020 Oct 21. pii: JVI.01193-20. doi: 10.1128/JVI.01193.
    PubMed     Abstract available


  186. KATO S, Shida H, Okamura T, Zhang X, et al
    CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    J Virol. 2020 Oct 21. pii: JVI.01718-20. doi: 10.1128/JVI.01718.
    PubMed     Abstract available


  187. OBREGON-PERKO V, Bricker K, Mensah G, Uddin F, et al
    SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques is Characterized by Elevated SHIV RNA in the Gut and High Abundance of Intact SHIV DNA in Naive CD4+ T cells.
    J Virol. 2020 Oct 21. pii: JVI.01669-20. doi: 10.1128/JVI.01669.
    PubMed     Abstract available


  188. HEMELAAR J, Loganathan S, Elangovan R, Yun J, et al
    Country-level diversity of the HIV-1 pandemic between 1990 and 2015.
    J Virol. 2020 Oct 21. pii: JVI.01580-20. doi: 10.1128/JVI.01580.
    PubMed     Abstract available


  189. MARTINS MA, Gonzalez-Nieto L, Ricciardi MJ, Bailey VK, et al
    Rectal Acquisition of SIVmac239 Infection Despite Vaccine-Induced Immune Responses Against the Entire SIV Proteome.
    J Virol. 2020 Oct 7. pii: JVI.00979-20. doi: 10.1128/JVI.00979.
    PubMed     Abstract available


  190. STINN T, Kuntz S, Varon D, Huang ML, et al
    Subclinical genital herpes shedding in HIV/HSV-2 co-infected women during antiretroviral therapy (ART) is associated with an increase in HIV tissue reservoirs and potentially promotes HIV evolution.
    J Virol. 2020 Oct 7. pii: JVI.01606-20. doi: 10.1128/JVI.01606.
    PubMed     Abstract available


    September 2020
  191. SCHORCHT A, van den Kerkhof TLGM, Cottrell CA, Allen JD, et al
    Neutralizing antibody responses induced by HIV-1 envelope glycoprotein SOSIP trimers derived from elite neutralizers.
    J Virol. 2020 Sep 30. pii: JVI.01214-20. doi: 10.1128/JVI.01214.
    PubMed     Abstract available


  192. MAHE D, Matusali G, Deleage C, Alvarenga RLLS, et al
    Potential for virus endogenization in humans through testicular germ cell infection: the case of HIV.
    J Virol. 2020 Sep 30. pii: JVI.01145-20. doi: 10.1128/JVI.01145.
    PubMed     Abstract available


  193. MEZIANE O, Salahuddin S, Pham TNQ, Farnos O, et al
    HIV infection and persistence in pulmonary mucosal double negative T-cells in vivo.
    J Virol. 2020 Sep 23. pii: JVI.01788-20. doi: 10.1128/JVI.01788.
    PubMed     Abstract available


  194. MUSICH T, Thovarai V, Venzon DJ, Mohanram V, et al
    A prime/boost vaccine regimen alters the rectal microbiome and impacts immune responses and viremia control post-SIV infection in male and female rhesus macaques.
    J Virol. 2020 Sep 23. pii: JVI.01225-20. doi: 10.1128/JVI.01225.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: